Prospect: Information for the user
Captopril Qualigen 25 mg tablets
Read the entire prospectus carefully before starting to take this medication, as it contains important information for you.
Contents of the prospectus
Captopril Qualigen is a medication that belongs to the group of so-called angiotensin-converting enzyme inhibitors (ACE inhibitors). Captopril produces a relaxation of blood vessels and reduces blood pressure.
Captopril Qualigen is indicated for the treatment of:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Captopril Qualigen:
You should avoid excessive sweating and dehydration, which can lead to a sudden drop in blood pressure.
Other medications and Captopril Qualigen
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
Tell your doctor or pharmacist if you are taking any of the following medications used to treat high blood pressure:
Your doctor may monitor your kidney function, blood pressure, and blood electrolyte levels (e.g., potassium) at regular intervals.
See also the information under the heading "Do not take Captopril Qualigen."
Inform your doctor that you are taking Captopril Qualigen if you are going to undergo surgery or receive anesthetics.
As with other medications used to lower blood pressure, this medication may be less effective in black patients.
Consult your doctor, even if any of the above circumstances have occurred to you in the past.
Your doctor may need to adjust your dose and/or take other precautions:
Certain medications may interact with Captopril Qualigen. In these cases, it may be necessary to change the dose or discontinue treatment with one of them.
It is essential that you inform your doctor if you are taking any of the following medications:
Taking Captopril Qualigen with food
The tablets should be swallowed with water and can be taken with or without food. Inform your doctor if you take potassium supplements or follow a diet rich in potassium.
Pregnancy and lactation
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
The use of Captopril Qualigen is not recommended in the first trimester of pregnancy and is contraindicated in the second and third trimesters of pregnancy.
If administered during the second and third trimesters of pregnancy, angiotensin-converting enzyme inhibitors (the group to which captopril belongs) can cause fetal harm and death.
If pregnancy is detected, the administration of this medication should be discontinued as soon as possible.
Captopril Qualigen should not be administered during breastfeeding.
Driving and using machines
During treatment for high blood pressure, your ability to drive and use machines may be reduced, especially at the beginning of treatment, when the dose is changed, or when you consume alcohol. Do not drive or use machinery if you observe that this medication causes you any disability to perform these functions.
Captopril Qualigen contains lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow your doctor's instructions for taking Captopril Qualigen exactly. If you are unsure, consult your doctor again.
Remember to take your medication.
Your doctor will indicate the duration of treatment with Captopril Qualigen. Do not stop treatment before, as it may worsen your condition.
The dosage should be individualized, so your doctor will establish the appropriate dose for you and make any necessary adjustments.
Adults
High blood pressure
The recommended initial dose is 25-50 mg per day, taken in two daily doses. Your doctor may gradually increase the dose up to 100-150 mg per day. Your doctor may recommend taking other medications that lower blood pressure in combination.
Chronic heart failure
The recommended initial dose is 6.25-12.5 mg two or three times a day. Your doctor may gradually increase the dose up to a maximum of 150 mg per day.
Myocardial infarction
The usual dose is a test dose of 6.25 mg. Your doctor may gradually increase the dose up to a maximum of 150 mg per day.
Diabetic nephropathy type 1
The recommended initial dose is 75-100 mg per day, taken in several daily doses.
Use in children and adolescents
The recommended initial dose is 0.30 mg/kg of body weight. In children who require special precautions, the initial dose should be 0.15 mg/kg of body weight. The use of this medication in children and adolescents should be initiated under close medical supervision.
Elderly patients
In elderly patients with impaired renal function and other organic disorders, lower doses than those recommended should be administered.
Patients with renal insufficiency
Lower doses than those recommended should be administered.
If you think the effect of Captopril Qualigen is too strong or too weak, tell your doctor or pharmacist.
If you take more Captopril Qualigen than you should
If you have taken more Captopril Qualigen than you should, consult your doctor or pharmacist immediately.
The most common symptoms in case of overdose include severe hypotension, shock, stupor, bradycardia (slow heart rate), electrolyte disturbances, and kidney failure.
In case of overdose or accidental ingestion, consult the Toxicology Information Service. Phone 915 620 420.
If you forget to take Captopril Qualigen
Take the dose as soon as you remember on the same day. Do not take a double dose to make up for forgotten doses.
Like all medications, this medication can have side effects, although not everyone will experience them.
The classification of side effects is based on the following frequencies:
Very common (may affect up to 1 in 10 people)
Common (may affect less than 1 in 10 people)
Uncommon (may affect less than 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect less than 1 in 10,000 people)
Frequency not known (cannot be estimated from available data).
The following side effects have been observed:
Blood and lymphatic system disorders
Very rare:changes in blood cell count, lymph node disorders, autoimmune diseases.
Metabolic and nutritional disorders
Rare:anorexia (loss of appetite).
Very rare:changes in blood tests related to potassium and glucose levels.
Psychiatric disorders
Common:sleep disorders.
Very rare:confusion, depression.
Nervous system disorders
Common:taste disturbances, dizziness.
Rare:drowsiness, headache, and tingling sensation.
Very rare:fainting, fainting spells.
Eye disorders
Very rare:blurred vision.
Cardiac disorders
Uncommon:tachycardia, angina pectoris, palpitations.
Very rare:cardiac arrest, cardiogenic shock.
Vascular disorders
Uncommon:hypotension, Raynaud's syndrome (crises of paleness followed by cyanosis and rubor, which occurs in the fingers of the hand), flushing, pallor.
Respiratory, thoracic, and mediastinal disorders
Common:cough and difficulty breathing.
Very rare:respiratory disorders.
Gastrointestinal disorders
Common:nausea, vomiting, gastric irritation, abdominal pain, diarrhea, constipation, dry mouth.
Rare:mouth lesions.
Very rare:tongue inflammation, stomach ulcers, pancreatitis.
Hepatobiliary disorders
Very rare:liver disorders and yellowing of the skin, hepatitis (inflammation of the liver) including necrosis, elevations of liver enzymes and bilirubin.
Skin and subcutaneous tissue disorders
Common:itching with or without skin rash, skin rash, and hair loss.
Uncommon:swelling of the arms, legs, face, lips, tongue, and/or throat.
Very rare:appearance of blisters with itching, Stevens-Johnson syndrome, sensitivity to light, skin redness, skin peeling.
Musculoskeletal and connective tissue disorders
Very rare:muscle pain, joint pain.
Renal and urinary disorders
Rare:kidney function disorders, including kidney failure and changes in urine elimination.
Reproductive system and breast disorders
Very rare:impotence, abnormal breast development in men.
General disorders and administration site conditions
Uncommon:chest pain, fatigue, malaise.
Very rare:fever.
Investigations:
Very rare:changes in blood cell count in blood tests.
Reporting of side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Store in the original package and keep the package perfectly closed to protect it from moisture.
Do not store above 30°C.
Do not use Captopril Qualigen after the expiration date stated on the package after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through wastewater or household waste. Deposit the packages and medications you no longer need at the SIGRE point in the pharmacy. If in doubt, ask your pharmacist how to dispose of packages and medications you no longer need. This will help protect the environment.
Composition of Captopril Qualigen
Appearance and package contents
Captopril Qualigen is presented in tablet form. Each package contains 60 or 500 tablets.
Not all package sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Neuraxpharm Spain, S.L.U.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona – Spain
Manufacturer:
Neuraxpharm Pharmaceuticals, S.L.
Avda. Barcelona, 69
08970 Sant Joan Despí (Barcelona)
Spain
Date of last revision of this prospectus: September 2021
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/
The average price of CAPTOPRIL QUALIGEN 25 mg TABLETS in October, 2025 is around 3.53 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.